Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
9.71%
operating margin TTM
13.4%
revenue TTM
582.81 Million
revenue per share TTM
25.62$
valuation ratios | |
|---|---|
| pe ratio | 19.36 |
| peg ratio | 0.01 |
| price to book ratio | 3.09 |
| price to sales ratio | 2.04 |
| enterprise value multiple | 7.97 |
| price fair value | 3.09 |
profitability ratios | |
|---|---|
| gross profit margin | 52.63% |
| operating profit margin | 13.4% |
| pretax profit margin | 12.56% |
| net profit margin | 9.71% |
| return on assets | 6.31% |
| return on equity | 17.32% |
| return on capital employed | 10.47% |
liquidity ratios | |
|---|---|
| current ratio | 3.12 |
| quick ratio | 2.52 |
| cash ratio | 1.30 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 261.65 |
| operating cycle | 362.58 |
| days of payables outstanding | 127.11 |
| cash conversion cycle | 235.48 |
| receivables turnover | 3.62 |
| payables turnover | 2.87 |
| inventory turnover | 1.39 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.23 |
| debt equity ratio | 0.58 |
| long term debt to capitalization | 0.35 |
| total debt to capitalization | 0.37 |
| interest coverage | 3.87 |
| cash flow to debt ratio | 0.64 |
cash flow ratios | |
|---|---|
| free cash flow per share | 8.21 |
| cash per share | 14.88 |
| operating cash flow per share | 9.97 |
| free cash flow operating cash flow ratio | 0.82 |
| cash flow coverage ratios | 0.64 |
| short term coverage ratios | 10.81 |
| capital expenditure coverage ratio | 5.65 |
Frequently Asked Questions
When was the last time ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) reported earnings?
ANI Pharmaceuticals, Inc. (ANIP) published its most recent earnings results on 08-05-2026.
What is ANI Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)'s trailing twelve months ROE is 17.32%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ANI Pharmaceuticals, Inc. (ANIP) currently has a ROA of 6.31%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ANIP's net profit margin stand at?
ANIP reported a profit margin of 9.71% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ANIP's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.12 in the most recent quarter. The quick ratio stood at 2.52, with a Debt/Eq ratio of 0.58.